Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy

Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy

December 15, 2015 at 9:34 AM 0 comments

Summary of presentations from the Takeda-sponsored symposia held at the 23rd United European Gastroenterology Week in Barcelona, Spain, on 26th and 28th October 2015 Gut-Selective Biologic Therapy for Ulcerative Colitis: Lessons from Science and Practice Chairperson: Gert Van Assche1 Speakers: Axel U. Dignass,2 Britta Siegmund,3 William J. Sandborn4 Management ofRead More

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment

December 15, 2015 at 9:32 AM 0 comments

This symposium took place on 27th October 2015 as part of the United European Gastroenterology (UEG) Week 2015 in Barcelona, Spain Chairperson Remo Panaccione1 Speakers Remo Panaccione,1 Geert D’Haens,2 Brian Feagan3 1. Department of Medicine, University of Calgary, Calgary, Alberta, Canada 2. Inflammatory Bowel Disease Center, Academic Medical Center, Amsterdam,Read More

The Full Picture of Ulcerative Colitis: The Burden, the Patient, the Treatment

The Full Picture of Ulcerative Colitis: The Burden, the Patient, the Treatment

December 15, 2015 at 9:30 AM 0 comments

This symposium took place on 26th October 2015 as part of United European Gastroenterology (UEG) Week 2015 in Barcelona, Spain Chairperson Julián Panés1,2 Speakers Edouard Louis,3 Paul Rutgeerts4 1. Department of Medicine, University of Barcelona, Barcelona, Spain 2. International Clinical Observation Programs in the Inflammatory Bowel Diseases Unit, Hospital ClínicRead More

Gut Microbiota: Modulate its Complexity to Restore the Balance

Gut Microbiota: Modulate its Complexity to Restore the Balance

December 15, 2015 at 9:29 AM 0 comments

This symposium took place on 26th October 2015 as part of the 23rd United European Gastroenterology Week in Barcelona, Spain Chairperson Fermín Mearin1 Speakers Fermín Mearin,1 Antonio Gasbarrini,2 Peter Malfertheiner,3 Mark Pimentel4 1. Centro Médico Teknon, Barcelona, Spain 2. Gemelli University Hospital, Catholic University of Rome, Rome, Italy 3. OttoRead More

Cystic Pancreatic Lesions Beyond the Guidelines: Can we Make an Evidence-Based Decision Whether to Resect or to Observe?

Cystic Pancreatic Lesions Beyond the Guidelines: Can we Make an Evidence-Based Decision Whether to Resect or to Observe?

December 15, 2015 at 9:28 AM 0 comments

Giovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, Alex Borin, Claudio Bassi, *Roberto Salvia Department of Surgery, Pancreas Institute of Verona University, Verona, Italy *Correspondence to roberto.salvia@univr.it Disclosure: The authors have declared no potential conflicts of interest. Received: 30.07.15 Accepted: 24.08.15 Citation: EMJ Gastroenterol. 2015;4[1]:88-94. Abstract Pancreatic cystic neoplasms (PCNs) are noRead More

Management of Diverticulitis and Prevention of Recurrence

Management of Diverticulitis and Prevention of Recurrence

December 15, 2015 at 9:27 AM 0 comments

Paolo Andreozzi, Francesco Paolo Zito, Giovanni Sarnelli, *Rosario Cuomo Department of Clinical Medicine and Surgery, Gastroenterological Unit, University Federico II, Naples, Italy *Correspondence to rcuomo@unina.it Disclosure: The authors have declared no potential conflict of interest. Received: 30.07.15 Accepted: 21.08.15 Citation: EMJ Gastroenterol. 2015;4[1]:95-100. Abstract Acute diverticulitis is an acute inflammationRead More

An Update on the Treatment of  Helicobacter Pylori Infection

An Update on the Treatment of Helicobacter Pylori Infection

December 15, 2015 at 9:26 AM 0 comments

*Sinéad Marian Smith Department of Clinical Medicine, School of Medicine; School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland *Correspondence to smithsi@tcd.ie Disclosure: The author has declared no conflicts of interest. Received: 05.08.15 Accepted: 02.09.15 Citation: EMJ Gastroenterol. 2015;4[1]:101-107. Abstract Helicobacter pylori treatment is becoming a challenge inRead More

Perfect or Failed ERCP:  What Makes the Difference?

Perfect or Failed ERCP: What Makes the Difference?

December 15, 2015 at 9:25 AM 0 comments

*Julius Spicak, Tomas Hucl Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic *Correspondence to julius.spicak@ikem.cz Disclosure: The authors have declared no conflicts of interest. Received: 19.05.15 Accepted: 25.09.15 Citation: EMJ Gastroenterol. 2015;4[1]:108-113. Abstract Endoscopic retrograde cholangiopancreatography (ERCP) has become an effective and safe therapeutic method, providingRead More

Bridging Paediatric Liver Diseases to Adult Care: What Does the Gastroenterologist Need to Know?

Bridging Paediatric Liver Diseases to Adult Care: What Does the Gastroenterologist Need to Know?

December 15, 2015 at 9:24 AM 0 comments

*Deirdre A. Kelly University of Birmingham; The Liver Unit, Birmingham Children’s Hospital NHS Trust, Birmingham, UK *Correspondence to deirdre.kelly@bch.nhs.uk Disclosure: The author has declared no conflicts of interest. Received: 30.07.15 Accepted: 09.10.15 Citation: EMJ Gastroenterol. 2014;3:114-120. Abstract Advances in medical and surgical therapy mean that significant numbers of children withRead More

Hepatitis E in Europe: Diagnosis and Treatment

Hepatitis E in Europe: Diagnosis and Treatment

December 15, 2015 at 9:23 AM 0 comments

Charlotte M. Nijskens,1 Suzan D. Pas,2 Annemiek A. van der Eijk,2 *Robert A. de Man1 1. Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands 2. Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands *Correspondence to r.deman@erasmusmc.nl Disclosure: The authors have declared no conflicts of interest. Received: 22.05.15Read More